Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
143 | 64226 | 35.5 | 67% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
143 | 3 | EPILEPSY//EPILEPSIA//EPILEPSY & BEHAVIOR | 64226 |
41 | 2 | EPILEPSY//EPILEPSIA//EPILEPSY & BEHAVIOR | 31060 |
230 | 2 | ANTIEPILEPTIC DRUGS//LEVETIRACETAM//EPILEPSY | 20331 |
984 | 2 | KINDLING//EPILEPSY RESEARCH//KCC2 | 10569 |
3136 | 2 | KETOGENIC DIET//GLUT1 DEFICIENCY SYNDROME//KETOGENIC | 2266 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | EPILEPSY | authKW | 3578872 | 20% | 58% | 13139 |
2 | EPILEPSIA | journal | 2339891 | 10% | 75% | 6622 |
3 | EPILEPSY & BEHAVIOR | journal | 1105537 | 5% | 76% | 3083 |
4 | EPILEPSY RESEARCH | journal | 932762 | 4% | 72% | 2760 |
5 | CLINICAL NEUROLOGY | WoSSC | 911490 | 52% | 6% | 33131 |
6 | ANTIEPILEPTIC DRUGS | authKW | 899821 | 4% | 74% | 2567 |
7 | SEIZURES | authKW | 790370 | 6% | 41% | 4050 |
8 | SEIZURE-EUROPEAN JOURNAL OF EPILEPSY | journal | 681698 | 3% | 77% | 1869 |
9 | EPILEPSY SURGERY | authKW | 567436 | 2% | 76% | 1583 |
10 | TEMPORAL LOBE EPILEPSY | authKW | 543011 | 3% | 67% | 1720 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Clinical Neurology | 911490 | 52% | 6% | 33131 |
2 | Neurosciences | 126062 | 27% | 2% | 17454 |
3 | Psychiatry | 55409 | 11% | 2% | 7385 |
4 | Behavioral Sciences | 38128 | 6% | 3% | 3794 |
5 | Pediatrics | 17130 | 7% | 1% | 4231 |
6 | Pharmacology & Pharmacy | 12039 | 11% | 1% | 6749 |
7 | Neuroimaging | 9399 | 2% | 2% | 1056 |
8 | Medical Laboratory Technology | 1320 | 1% | 1% | 652 |
9 | Toxicology | 1051 | 2% | 1% | 1308 |
10 | Medicine, General & Internal | 731 | 3% | 0% | 2194 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EPILEPSY | 471526 | 3% | 59% | 1689 |
2 | NEUROL | 359717 | 22% | 6% | 13966 |
3 | COMPREHENS EPILEPSY | 136152 | 1% | 63% | 454 |
4 | EPILEPSY UNIT | 128959 | 1% | 68% | 404 |
5 | CLIN EXPT EPILEPSY | 121794 | 1% | 55% | 472 |
6 | PEDIAT NEUROL | 95255 | 2% | 17% | 1188 |
7 | COMPREHENS EPILEPSY PROGRAM | 80078 | 0% | 76% | 222 |
8 | EPILEPTOL | 70237 | 1% | 36% | 420 |
9 | CHILD NEUROL | 59148 | 1% | 19% | 662 |
10 | EPILEPSY GRP | 55949 | 0% | 72% | 165 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EPILEPSIA | 2339891 | 10% | 75% | 6622 |
2 | EPILEPSY & BEHAVIOR | 1105537 | 5% | 76% | 3083 |
3 | EPILEPSY RESEARCH | 932762 | 4% | 72% | 2760 |
4 | SEIZURE-EUROPEAN JOURNAL OF EPILEPSY | 681698 | 3% | 77% | 1869 |
5 | EPILEPTIC DISORDERS | 211868 | 1% | 67% | 672 |
6 | JOURNAL OF EPILEPSY | 115955 | 0% | 79% | 312 |
7 | NEUROLOGY | 82431 | 3% | 9% | 1950 |
8 | BRAIN & DEVELOPMENT | 57658 | 1% | 19% | 670 |
9 | JAPANESE JOURNAL OF PSYCHIATRY AND NEUROLOGY | 56144 | 1% | 35% | 344 |
10 | JOURNAL OF CHILD NEUROLOGY | 51006 | 1% | 15% | 730 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | EPILEPSY | 3578872 | 20% | 58% | 13139 | Search EPILEPSY | Search EPILEPSY |
2 | ANTIEPILEPTIC DRUGS | 899821 | 4% | 74% | 2567 | Search ANTIEPILEPTIC+DRUGS | Search ANTIEPILEPTIC+DRUGS |
3 | SEIZURES | 790370 | 6% | 41% | 4050 | Search SEIZURES | Search SEIZURES |
4 | EPILEPSY SURGERY | 567436 | 2% | 76% | 1583 | Search EPILEPSY+SURGERY | Search EPILEPSY+SURGERY |
5 | TEMPORAL LOBE EPILEPSY | 543011 | 3% | 67% | 1720 | Search TEMPORAL+LOBE+EPILEPSY | Search TEMPORAL+LOBE+EPILEPSY |
6 | STATUS EPILEPTICUS | 367679 | 2% | 60% | 1303 | Search STATUS+EPILEPTICUS | Search STATUS+EPILEPTICUS |
7 | LEVETIRACETAM | 278789 | 1% | 78% | 757 | Search LEVETIRACETAM | Search LEVETIRACETAM |
8 | ANTICONVULSANTS | 260599 | 2% | 45% | 1229 | Search ANTICONVULSANTS | Search ANTICONVULSANTS |
9 | KETOGENIC DIET | 204206 | 1% | 77% | 558 | Search KETOGENIC+DIET | Search KETOGENIC+DIET |
10 | LAMOTRIGINE | 193893 | 1% | 55% | 744 | Search LAMOTRIGINE | Search LAMOTRIGINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BROPHY, GM , BELL, R , CLAASSEN, J , ALLDREDGE, B , BLECK, TP , GLAUSER, T , LAROCHE, SM , RIVIELLO, JJ , SHUTTER, L , SPERLING, MR , ET AL (2012) GUIDELINES FOR THE EVALUATION AND MANAGEMENT OF STATUS EPILEPTICUS.NEUROCRITICAL CARE. VOL. 17. ISSUE 1. P. 3-23 | 203 | 91% | 226 |
2 | PATSALOS, PN , BERRY, DJ , BOURGEOIS, BFD , CLOYD, JC , GLAUSER, TA , JOHANNESSEN, SI , LEPPIK, IE , TOMSON, T , PERUCCA, E , (2008) ANTIEPILEPTIC DRUGS - BEST PRACTICE GUIDELINES FOR THERAPEUTIC DRUG MONITORING: A POSITION PAPER BY THE SUBCOMMISSION ON THERAPEUTIC DRUG MONITORING, ILAE COMMISSION ON THERAPEUTIC STRATEGIES.EPILEPSIA. VOL. 49. ISSUE 7. P. 1239 -1276 | 287 | 83% | 249 |
3 | MORIMOTO, K , FAHNESTOCK, M , RACINE, RJ , (2004) KINDLING AND STATUS EPILEPTICUS MODELS OF EPILEPSY: REWIRING THE BRAIN.PROGRESS IN NEUROBIOLOGY. VOL. 73. ISSUE 1. P. 1-60 | 360 | 61% | 424 |
4 | SARCO, DP , BOURGEOIS, BFD , (2010) THE SAFETY AND TOLERABILITY OF NEWER ANTIEPILEPTIC DRUGS IN CHILDREN AND ADOLESCENTS.CNS DRUGS. VOL. 24. ISSUE 5. P. 399-430 | 309 | 90% | 1 |
5 | LAXER, KD , TRINKA, E , HIRSCH, LJ , CENDES, F , LANGFITT, J , DELANTY, N , RESNICK, T , BENBADIS, SR , (2014) THE CONSEQUENCES OF REFRACTORY EPILEPSY AND ITS TREATMENT.EPILEPSY & BEHAVIOR. VOL. 37. ISSUE . P. 59 -70 | 190 | 95% | 38 |
6 | CONNOCK, M , FREW, E , EVANS, BW , BRYAN, S , CUMMINS, C , FRY-SMITH, A , PO, ALW , SANDERCOCK, J , (2006) THE CLINICAL EFFECTIVENESS AND COST-EFFECTIVENESS OF NEWER DRUGS FOR CHILDREN WITH EPILEPSY. A SYSTEMATIC REVIEW.HEALTH TECHNOLOGY ASSESSMENT. VOL. 10. ISSUE 7. P. 1-+ | 280 | 92% | 32 |
7 | DUNCAN, JS , (1997) IMAGING AND EPILEPSY.BRAIN. VOL. 120. ISSUE . P. 339 -377 | 282 | 87% | 298 |
8 | SPENCER, S , HUH, L , (2008) OUTCOMES OF EPILEPSY SURGERY IN ADULTS AND CHILDREN.LANCET NEUROLOGY. VOL. 7. ISSUE 6. P. 525-537 | 164 | 98% | 261 |
9 | GAITATZIS, A , SANDER, JW , (2013) THE LONG-TERM SAFETY OF ANTIEPILEPTIC DRUGS.CNS DRUGS. VOL. 27. ISSUE 6. P. 435-455 | 233 | 84% | 17 |
10 | MOSHE, SL , PERUCCA, E , RYVLIN, P , TOMSON, T , (2015) EPILEPSY: NEW ADVANCES.LANCET. VOL. 385. ISSUE 9971. P. 884 -898 | 118 | 89% | 69 |
Classes with closest relation at Level 3 |